MED 7 LLC AND HEMPCO IC. ANNOUNCE THE PUBLICATION OF THE FIRST PROSPECTIVE HUMAN CLINICAL TRIAL USING A CBD-RICH FULL-SPECTRUM HEMP OIL IN PATIENTS WITH COVID-19
Bluffdale, UT, May 12, 2022 – Med 7, LLC (www.Med 7cbd.com), and HempCo, Inc., Lone Tree, CO, announce the completion and publication of the first prospective human clinical study to assess the effects of a CBD-rich full-spectrum hemp oil in patients with COVID-19 (SARS-CoV-2). The study used Med 7, a full-spectrum hemp product made with Purzorb® technology, now trademarked as Hempzorb81™.